Skip to main content
Download PDF

Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia

Biomarker Research volume 7, Article number: 21 (2019) Cite this article

The Original Article was published on 11 September 2019

Correction to: Biomark Res (2019) 7:19

https://doi.org/10.1186/s40364-019-0170-2

The original article [1] contains an error in the legend of Fig. 1 whereby it is incorrectly stated that MEC stands for ‘mitoxantrone, etoposide, cyclophosphamide’.

It should instead be stated that MEC stands for ‘mitoxantrone, etoposide, cytarabine’.

Reference

  1. Zhao J, Song Y, Liu D. Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia. Biomarker Research. 2019;7:19. https://doi.org/10.1186/s40364-019-0170-2.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, The first Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    Juanjuan Zhao, Yongping Song & Delong Liu

  2. Division of Hematology and Oncology, New York Medical College, Valhalla, USA

    Delong Liu

Authors
  1. Juanjuan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yongping Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Delong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yongping Song or Delong Liu.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, J., Song, Y. & Liu, D. Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia. Biomark Res 7, 21 (2019). https://doi.org/10.1186/s40364-019-0172-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40364-019-0172-0

Biomarker Research

ISSN: 2050-7771

Contact us